Interaction of ALK Inhibitors with Polyspecific Organic Cation Transporters and the Impact of Substrate-Dependent Inhibition on the Prediction of Drug–Drug Interactions

Small molecules targeting aberrant anaplastic lymphoma kinase (ALK) are active against ALK-positive non-small-cell lung cancers and neuroblastoma. Several targeted tyrosine kinase inhibitors (TKIs) have been shown to interact with polyspecific organic cation transporters (pOCTs), raising concerns ab...

Full description

Bibliographic Details
Published in:Pharmaceutics
Main Authors: Yik Pui Tsang, Antonio Jesús López Quiñones, Letícia Salvador Vieira, Joanne Wang
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/9/2312